ArticleEClinicalMedicine2022

Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases.

Jingjing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.